Pancreatic Cancer Research

ResearcherNorth Carolina Central UniversityActive in the last 2 years

Antonio T. Baines

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0003-3547-8274; OpenAlex author ID A5103441103. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organo… Co-author DOI 10.3389/fphar.2026.1685433↗
  2. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. Co-author DOI 10.1371/journal.pone.0294065↗
  3. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. Co-author DOI 10.1177/2472555218773045↗
  4. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer. Co-author DOI 10.1016/bs.pmbts.2016.09.006↗
  5. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine. Last author DOI 10.4161/cbt.24343↗
  6. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells. Last author DOI 10.1093/carcin/bgr007↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph F. LaComb · 2 shared papers, 2023–2026 · strength 0.53
  2. Agnieszka Beata Bialkowska · 2 shared papers, 2023–2026 · strength 0.53
  3. Lee M. Graves · 2 shared papers, 2018–2023 · strength 0.30
  4. Emma Wen · 1 shared paper, 2026 · strength 0.29
  5. Fatim M. Kouassi · 1 shared paper, 2026 · strength 0.29
  6. David Arthur Tuveson · 1 shared paper, 2026 · strength 0.29
  7. Komala Ingle · 1 shared paper, 2023 · strength 0.24
  8. Checo J. Rorie · 1 shared paper, 2016 · strength 0.10
  9. Jen Jen Yeh · 2 shared papers, 2011–2018 · strength 0.09
  10. Gary L. Johnson · 1 shared paper, 2018 · strength 0.07
  11. Linas J. Krulikas · 1 shared paper, 2018 · strength 0.07
  12. Dapeng Xu · 1 shared paper, 2013 · strength 0.03
  13. ALBERT Sidney BALDWIN · 1 shared paper, 2013 · strength 0.03
  14. Adrienne D. Cox · 1 shared paper, 2011 · strength 0.03
  15. D. Xu · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.